State Of Wisconsin Investment Board Glycomimetics Inc Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$2.8 - $12.85 $130,199 - $597,525	-46,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.6 - $13.12 $10,600 - $13,120	1,000 Added 2.2%	46,500 $554,000
Q1 2019 May 13, 2019	BUY	$9.96 - $13.44 $104,580 - $141,120	10,500 Added 30.0%	45,500 $567,000
Q4 2018 Feb 11, 2019	BUY	$8.47 - $14.71 $28,798 - $50,014	3,400 Added 10.76%	35,000 $331,000
Q2 2018 Aug 03, 2018	BUY	$14.63 - $19.19 $462,308 - $606,404	31,600 New	31,600 $510,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $22M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.